In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Marillion Pharmaceuticals Inc.

Latest From Marillion Pharmaceuticals Inc.

Marillion Pharmaceuticals Inc.

A spinout from the University of Pennsylvania's radiology department, Marillion Pharmaceuticals INc. is developing cancer treatments that pack lethal drugs into tiny nanoparticles. Marillion aims to deliver multiple cancer fighting drugs together with imaging moieties in a single nanoscale device, enabling physicians to see the effect of the targeted delivery of these powerful drug cocktails.

Start-Up Previews (01/06)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups are Stopping Migraine Pain--Novel Therapies Move beyond Triptans and Devices Fill the Lung Space. Plus these Start-Ups Across Health Care: CeNeRx BioPharma, Lentigen, Marillion Pharmaceuticals and Restore Medical.
See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Marillion Pharmaceuticals Inc.
  • Senior Management
  • Zahed Subhan, PhD, Pres. & CEO
  • Contact Info
  • Marillion Pharmaceuticals Inc.
    Phone: (484) 875-3018
    102 Pickering Way
    Ste. 200
    Exton, PA 19341